Seelos therapeutics to participate in the 12th annual lifesci partners corporate access event

New york , dec. 22, 2022 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 12th annual lifesci partners corporate access event, to be held in san francisco, california on january 9-11 th, 2023. "we are delighted to participate in this annual event once again and excited to see that it is in-person this year," said raj mehra, ph.d.
SEEL Ratings Summary
SEEL Quant Ranking